Q1 2022 Holdings
Filed 2022-05-16 | 41 holdings | $44.7M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Aadi Biosciences Inc(WHWK) | COM | 00032Q104 | $26.0M | 1,529,402 | 58.1% |
| Celldex Therapeutics Inc(CLDX) | COM NEW | 15117B202 | $11.0M | 322,898 | 24.6% |
| Arrowhead Pharmaceuticals Inc(ARWR) | COM | 04280A100 | $3.8M | 82,500 | 8.5% |
| Aclaris Therapeu(ACRS) | COM | 00461U105 | $3.8M | 217,600 | 8.4% |
| Apellis Pharmaceuticals Inc(APLS) | COM | 03753U106 | $28.1K | 554,000 | 0.1% |
| Vistagen Therapeutics Inc(VTGNUSD) | COM NEW | 92840H202 | $14.6K | 11,736,283 | 0.0% |
| Relmada Therapeutics Inc(RLMD) | COM | 75955J402 | $9.2K | 342,000 | 0.0% |
| Iveric BIO Inc(OPHTEUR) | COM | 46583P102 | $9.1K | 539,500 | 0.0% |
| Bcls Acquisition Corp | COM CL A | G0904B105 | $8.3K | 843,122 | 0.0% |
| GH Research PLC(GHRS) | ORDINARY SHARES | G3855L106 | $7.7K | 419,632 | 0.0% |
| Kura Oncology Inc. Common Stock(KURA) | COM | 50127T109 | $7.6K | 473,969 | 0.0% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $6.9K | 225,000 | 0.0% |
| Viridian Therapeutics Inc(VRDN) | COM | 92790C104 | $6.3K | 340,000 | 0.0% |
| Merus NV | COM | N5749R100 | $6.2K | 235,500 | 0.0% |
| Bellus Health Inc(BLU) | COM NEW | 07987C204 | $5.6K | 816,000 | 0.0% |
| Jiya Acquisition Corp | COM CL A | 47760M102 | $5.5K | 562,500 | 0.0% |
| Jounce Therapeutics Inc(JNCEEUR) | COM | 481116101 | $5.5K | 813,500 | 0.0% |
| Fulcrum Therapeutics Inc(FULC) | COM | 359616109 | $4.7K | 200,000 | 0.0% |
| Mirati Therapeutics(MRTXEUR) | COM | 60468T105 | $4.3K | 52,500 | 0.0% |
| Avadel Pharmaceuticals PLC | SPONSORED ADR | 05337M104 | $4.0K | 580,000 | 0.0% |
| Health Sciences Acquisitions | ORD SHS | G4411D109 | $3.9K | 392,500 | 0.0% |
| Eyepoint Pharmaceuticals Inc(EYPT) | COM NEW | 30233G209 | $3.7K | 307,944 | 0.0% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $3.6K | 206,126 | 0.0% |
| Horizon Therapeutics PLC | SHS | G46188101 | $3.5K | 33,200 | 0.0% |
| PMV Pharmaceuticals Inc(PMVP) | COM | 69353Y103 | $2.8K | 135,500 | 0.0% |
| Harpoon Therapeutics Inc | COM | 41358P106 | $2.5K | 497,500 | 0.0% |
| Milestone Pharmaceuticals in(MIST) | COM | 59935V107 | $2.4K | 380,000 | 0.0% |
| Call- Pmvp 100 @ 20 EXP 06/17/2022(PMVP)Call | COM | 69353Y103 | $2.1K | 100,000 | 0.0% |
| Iovance Biotherapeutics Inc(IOVA) | COM | 462260100 | $2.0K | 118,856 | 0.0% |
| Athira Pharma Inc | COM | 04746L104 | $1.9K | 140,030 | 0.0% |
| Verastem Inc | COM | 92337C104 | $1.4K | 996,951 | 0.0% |
| Call- Atha 100@12 1/2 EXP 07/15/2022Call | COM | 04746L104 | $1.4K | 100,000 | 0.0% |
| Molecular Templates Inc | COM | 608550109 | $1.1K | 307,125 | 0.0% |
| Ventyx Biosciences Inc(VTYX) | COM | 92332V107 | $962 | 70,877 | 0.0% |
| Pyxis Oncology Inc(PYXS) | COMMON STOCK | 747324101 | $808 | 200,000 | 0.0% |
| Dice Therapeutics Inc | COM | 23345J104 | $717 | 37,500 | 0.0% |
| Call- Aciu 100@7 1/2Exp 08/19/2022(ACIU)Call | SHS | H00263105 | $400 | 100,000 | 0.0% |
| Immunogen Inc(IMGNEUR) | COM | 45253H101 | $262 | 55,000 | 0.0% |
| Seelos Therapeutics Inc | COM | 81577F109 | $248 | 295,896 | 0.0% |
| Enanta Pharmaceuticals Inc(ENTA) | COM | 29251M106 | $164 | 2,300 | 0.0% |
| Nuvation Warrants(NUVB) | *W EXP 07/07/202 | 67080N101 | $69 | 90,832 | 0.0% |